News
3d
GlobalData on MSNBoehringer Ingelheim begins Phase II trial of BI 1584862 for geographic atrophyThe study aims to identify the optimal dose of BI 1584862 and observe its impact on improving GA patients' eyes.
In reducing federal funding and downsizing federal health agencies, the Trump administration is impeding cancer research.
In February, one of the groups, the Charter Cities Institute, released its proposal to transform Guantánamo through ...
An AI model using serial brain scans predicted glioma recurrence in children with up to 89% accuracy, outperforming ...
Researchers have developed an AI system that predicts brain tumor recurrence in children using sequential MRI scans. By ...
5."It felt like an extremely well-rounded profession. You get to do inpatient and outpatient. You get to do office procedures ...
In an interview with HT Lifestyle, Asad Hussain, Founder and CEO at OddsFitness, shared, “Your digestive system influences much more than just your stomach, it's the cornerstone of overall health, ...
4d
Pharmaceutical Technology on MSNEli Lilly signs $415m deal for Alchemab’s ALS therapyThe deal builds on an existing research collaboration between Eli Lilly and Alchemab to discover new ALS drugs.
A technological revolution is helping Scripps Research scientists see the molecules that undermine human health, from ...
Additional research is needed on the efficacy, safety, and appropriate uses of various cosmeceuticals for patients’ skin care concerns.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results